Related Experiment Video
Updated: May 27, 2026

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV
Published on: November 10, 2023
Persistent symptoms and healthcare utilisation during five-year follow-up after SARS-CoV-2 infection: A multicentre
Mónica Gozalo-Margüello1, Claudia González-Rico2, Concepción Fariñas-Álvarez3
1Microbiology Service. Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, Cantabria, Spain; CIBER de Enfermedades Infecciosas (CB21/13/00068), Instituo de Salud Carlos III, Santander, Cantabria, Spain.
Objectives:
To describe long-term symptom persistence and healthcare utilisation related to SARS-CoV-2 infection over a five-year follow-up period in a multicentre cohort of patients with confirmed COVID-19 in Spain.
Methods:
We conducted a multicentre cohort study including individuals aged ≥ 16 years with RT-PCR-confirmed SARS-CoV-2 infection in Cantabria, Spain, between March 2020 and March 2022. Early follow-up (1-2 years post-infection) involved in-person interviews using a standardised questionnaire. Late follow-up (5 years post-infection) was based on electronic health record review. Outcomes included persistent symptoms, long COVID diagnoses, and healthcare utilisation related to post-COVID symptoms.
Results:
The cohort included 266 participants (198 hospitalised and 68 non-hospitalised). Among 200 participants with available early follow-up, 112/200 (56.0%) reported at least one persistent symptom during the medium-term post-infection period (1-2 years after SARS-CoV-2 infection). Persistent symptoms occurred in 76/132 (57.6%) hospitalised participants and in 36/68 (53.0%) non-hospitalised participants. Fatigue was the most frequent symptom in both groups. Only 9 participants (3.4%) had a formal diagnosis of long COVID recorded in their medical records. Female sex, chest pain during acute infection, and smoking were associated with symptom persistence. At five-year follow-up, 38 participants (14.3% of the total cohort; 19.0% of those with early follow-up) sought healthcare for symptoms compatible with post-COVID conditions. However, these encounters were not formally attributed to prior SARS-CoV-2 infection in the medical records.
Conclusions:
Persistent symptoms were common during the medium-term post-infection period, while formal long COVID diagnoses and healthcare encounters explicitly attributed to COVID-19 were relatively uncommon in routine clinical records at five years. These findings highlight the challenges of recognising and attributing long-term post-COVID manifestations in clinical practice and suggest that the burden of long-term post-COVID symptoms may be under-recognised in healthcare systems.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Investigation of Disease Outbreaks
Asthma-III: Symptoms and Complications
Classification of Asthma
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
